Evelo Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
EVLO Nasdaq 8731 https://evelobio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Evelo Biosciences Inc

Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights - Aug 14th, 2023 11:30 am
Moderna Co-Founder’s Firm Bought Up This Embattled Biotech Stock - Jul 18th, 2023 7:00 am
Evelo Biosciences Closes $25.5 Million Private Placement - Jul 12th, 2023 11:30 am
Evelo Biosciences Announces $25.5 Million Private Placement - Jul 10th, 2023 11:30 am
Evelo Biosciences Announces Reverse Stock Split Effective - Jun 29th, 2023 1:00 pm
What Makes Evelo Biosciences, Inc. (EVLO) a New Buy Stock - May 17th, 2023 4:00 pm
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry - May 16th, 2023 10:00 am
Evelo Biosciences Insiders Added US$575k Of Stock To Their Holdings \ - May 10th, 2023 12:42 pm
Evelo Biosciences' Atopic Dermatitis Study Cohort Misses Primary Goal Again, Shuts Study, Lays Off More Staff - Apr 26th, 2023 7:51 pm
Flagship-backed startup makes layoffs for second time in three months - Apr 26th, 2023 7:37 pm
Evelo Biosciences Provides Clinical Updates - Apr 26th, 2023 11:30 am
Evelo Biosciences, Inc. (NASDAQ:EVLO) Q4 2022 Earnings Call Transcript - Mar 21st, 2023 2:46 am
Q4 2022 Evelo Biosciences Inc Earnings Call - Mar 17th, 2023 2:23 am
Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights - Mar 16th, 2023 11:00 am
Evelo Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023 - Mar 9th, 2023 11:00 am
After Plunging -40.39% in 4 Weeks, Here's Why the Trend Might Reverse for Evelo Biosciences, Inc. (EVLO) - Mar 1st, 2023 2:35 pm
Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference - Mar 1st, 2023 11:00 am
Evelo Biosciences Reports that EDP2939, its First Oral Extracellular Vesicle Product Candidate, Commenced Dosing in a Phase 2 Psoriasis Trial - Feb 27th, 2023 11:00 am
Down -39.46% in 4 Weeks, Here's Why Evelo Biosciences, Inc. (EVLO) Looks Ripe for a Turnaround - Feb 13th, 2023 2:35 pm
Flagship-backed biotech cuts nearly half its staff - Feb 1st, 2023 6:56 pm